Reaction

Conjunctival Hyperaemia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,520 reports · 87 co-occurring drugs

As of the last recalculation, Conjunctival Hyperaemia appears in 3,520 FAERS reports alongside 87 co-occurring drug terms. The strongest observed disproportionality signal is BRINZOLAMIDE (PRR 33.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Brinzolamide	49	33.8	34.0
Brimonidine Tartrate	77	26.1	26.2
Tobramycin Solution	45	22.4	22.5
Tobramycin Sulfate	45	21.8	21.8
Timolol Maleate	34	20.5	20.5
Timolol	39	19.3	19.3
Moxifloxacin Hydrochloride	61	18.1	18.1
Bimatoprost	84	17.6	17.7
Nevirapine	26	17.2	17.2
Dorzolamide Hydrochloride And Timolol Maleate	22	16.6	16.6
Tobramycin	64	16.0	16.0
Prednisolone Acetate	27	15.5	15.6
Carboxymethylcellulose Sodium	24	15.2	15.2
Iohexol	20	14.3	14.4
Moxifloxacin	32	13.5	13.6
Latanoprost	103	12.4	12.5
Travoprost	17	11.7	11.7
Atropine Sulfate	19	10.5	10.5
Lamotrigine	213	10.1	10.1
Ranibizumab	42	9.5	9.5
Ampicillin	13	9.3	9.3
Ampicillin Sodium	13	9.3	9.3
Minocycline	18	9.2	9.2
Valproate Sodium	31	8.9	9.0
Ciclesonide	19	8.3	8.3
Lamotirigine	93	7.9	7.9
Lamotrigine Extended-Release	93	7.9	7.9
Lamotrigine Chewable Dispersible	93	7.9	7.9
Cefuroxime	15	7.8	7.8
Dexamethasone Sodium Phosphate	13	7.6	7.6
Carbamazepine	83	7.5	7.5
Erythromycin	23	7.3	7.3
Levofloxacin	73	7.3	7.3
Levofloxacin In 5% Dextrose	73	7.3	7.3
Phenobarbital	16	6.6	6.6
Cefazolin	10	6.5	6.5
Lifitegrast	17	6.2	6.2
Cefazolin Sodium	12	5.9	5.9
Zidovudine	13	5.8	5.8
Amphetamine	8	5.7	5.7
Gentamicin Sulfate	15	5.6	5.6
Phenytoin	19	5.4	5.4
Aflibercept	28	5.3	5.3
Valproic Acid	28	5.3	5.3
Oseltamivir	7	5.2	5.2
Hydrocortisone Sodium Succinate	8	5.0	5.0
Atropine	7	5.0	5.0
Gentamicin	11	5.0	5.0
Clarithromycin	28	4.9	4.9
Diclofenac	66	4.6	4.6
Lithium Carbonate	13	4.5	4.5
Propofol	27	4.4	4.4
Isoniazid	12	4.4	4.4
Febuxostat Tablets 40 Mg	7	4.1	4.1
Febuxostat Tablets 80 Mg	7	4.1	4.1
Dextrose	9	4.0	4.1
Dextrose Monohydrate	9	4.0	4.0
Sildenafil Powder,	23	3.8	3.8
Pyrazinamide	6	3.8	3.8
Diclofenac Sodium	91	3.6	3.6
Oseltamivir Phosphate	15	3.6	3.6
Triamcinolone Acetonide Ointment Usp, 0.05%	14	3.5	3.5
Rifampicin	6	3.5	3.5
Micafungin Sodium	5	3.5	3.5
Zoledronic Acid	23	3.4	3.4
Miconazole Nitrate	5	3.4	3.4
Pegaspargase	7	3.4	3.4
Canakinumab	6	3.3	3.3
Alteplase	8	3.2	3.2
Erlotinib	5	3.1	3.1
Panitumumab	8	3.0	3.0
Faricimab	4	2.9	2.9
Erlotinib Hydrochloride	6	2.8	2.8
Diclofenac Potassium, Film Coated	4	2.8	2.8
Diclofenac Potassium Tablets	4	2.8	2.8
Levocetirizine Dihydrochloride	11	2.7	2.7
Tolvaptan	6	2.4	2.4
Axicabtagene Ciloleucel	4	2.4	2.4
Irinotecan Hydrochloride	5	2.3	2.3
Oxaliplatin	28	2.2	2.2
Diclofenac Potassium	4	2.2	2.2
Vemurafenib	4	2.0	2.0
Cenegermin-Bkbj	4	2.0	2.0
Cetuximab	10	1.9	1.9
Encorafenib	3	1.8	1.8
Isotretinoin	12	1.4	1.4
Dupilumab	79	1.0	1.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.